Improving cancer research through advanced proteomics technologies
Official title: Advancing Proteomics Technologies for Cancer Research
Funded at Columbia University Health Sciences · NIH-10978094 · Data updated 2026-11-12
This study is exploring new ways to understand cancer better and find better treatments by using advanced technology, and it aims to help patients by discovering new targets for immunotherapy and improving how we treat tumors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 4, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $169,932 |
| NIH project number | 1R50CA293857-01 |
| Project ID | NIH-10978094 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals diagnosed with various types of cancer who are seeking innovative treatment options.
✕Less likely to help
Patients with non-malignant conditions or those not diagnosed with cancer may not receive any benefit from this research.
What this research studies
This research focuses on enhancing proteomics technologies to better understand cancer biology and improve treatment options. By utilizing advanced mass spectrometry and innovative methodologies, the project aims to identify novel immunotherapy targets and elucidate mechanisms driving tumor development. The work is conducted at the Herbert Irving Comprehensive Cancer Center, where the team collaborates with various cancer research programs to support advancements in precision oncology and tumor biology. Patients may benefit from the insights gained through this research, which could lead to more effective cancer therapies.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective cancer treatments and improved patient outcomes.
How similar studies have gone: Other research has shown success with similar proteomics approaches, indicating a promising avenue for advancing cancer treatment.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Soni, Rajesh Kumar — Columbia University Health Sciences
- Study coordinator: Soni, Rajesh Kumar
Related research
Other NIH-funded projects on the same topics.
-
Precision phenotyping of emphysema in the elderly: a study in diverse adults
Researchers will look at CT scans and lung tests in older adults to understand different forms of emphysema and how they relate to health outcomes.
-
HPV-based cervical cancer screening and treatment implementation in resource-limited settings
A collaborative project to help doctors in South Africa put HPV-based screening and same-day treatment for cervical cancer into routine care, so more people get fast, effective care.
-
Cervical cancer screening and treatment rollout in resource-poor settings
A team from Columbia and the University of Cape Town is testing how to best implement affordable, same-day HPV-based screen-and-treat for cervical cancer in public health settings.
-
Understanding SCN3A-related Developmental Epileptic Encephalopathy and Finding Better Treatments
This NIH grant focuses on how SCN3A gene variants cause developmental epileptic encephalopathy and aims to develop more effective therapies for affected patients.
-
mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support
A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.
-
M-CaRE: Mobile clinics and a smart heart-lung care tool for multimorbidity
A mobile, multilingual tool plus community health workers will help screen and manage high blood pressure and COPD in diverse adult patients, especially in underserved areas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.